Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 7,300 | 1,907 | 3,995 | 1,727 | 1,701 |
| Gross Profit | 7,300 | 1,907 | 3,995 | 1,727 | 1,701 |
| Operating Expenses | 26,703 | 20,703 | 23,015 | 20,203 | 24,522 |
| Operating Income | -19,403 | -18,796 | -19,020 | -18,476 | -22,821 |
| Other Income | -20 | 211 | 84 | 975 | -437 |
| Pre-tax Income | -19,423 | -18,585 | -18,936 | -17,501 | -23,258 |
| Net Income Continuous | -19,423 | -18,585 | -18,936 | -17,501 | -23,258 |
| Net Income | $-19,423 | $-18,585 | $-18,936 | $-17,501 | $-23,258 |
| EPS Basic Total Ops | -0.66 | -0.59 | -0.86 | -0.85 | -1.22 |
| EPS Basic Continuous Ops | -0.66 | -0.60 | -0.86 | -0.85 | -1.19 |
| EPS Diluted Total Ops | -0.66 | -0.59 | -0.86 | -0.85 | -1.22 |
| EPS Diluted Continuous Ops | -0.66 | -0.60 | -0.86 | -0.85 | -1.19 |
| EBITDA(a) | $-19,244 | $-18,605 | $-18,829 | $-18,286 | $-22,632 |